Farallon Capital Management, L.l.c.

San Francisco, CA 87 processed 13Fs on this site, 2021 Q3 to 2026 Q2

$21.7B
77 holdings
2026 Q2
+23.6% QoQ
Top 5 29.9%

Portfolio

2026 Q2, filed 8/14/2026, top 12 of 77 holdings

Top 5 29.9%, top 10 44.0%

AUM over time

2026 Q2 $21.7B +23.6% QoQ

Q3 2021

Q1 2022

Q1 2023

Q1 2024

Q1 2025

Q1 2026

Book

2023 Q3 2023 Q2, filed 14 Nov, long equity only

Download CSV Download Excel All activity


Activision Blizzard	9.54%	New	20,320,000	$93.63	$1.9B	+20,320,000	+$1.9B
Horizon Therapeutics Pub	3.86%	New	6,656,823	$115.69	$770M	+6,656,823	+$770M
UNH, UnitedHealth Group	3.40%, was 3.38%	Add +7.0%	1,346,700	$504.19	$679M	+87,900	+$74M
TRU, Transunion	3.32%, was 4.08%	Reduce −1.0%	9,233,256	$71.79	$663M	−91,537	−$68M
EXEL, Exelixis	2.83%	Hold	25,860,000	$21.85	$565M	—	—
IQV, IQVIA	2.73%, was 4.86%	Reduce −28.5%	2,766,332	$196.75	$544M	−1,100,780	−$325M
TMO, Thermo Fisher Scientific	2.66%, was 3.63%	Reduce −15.8%	1,047,531	$506.17	$530M	−196,128	−$119M
CRM, Salesforce	2.57%, was 2.30%	Add +29.9%	2,525,638	$202.78	$512M	+581,300	+$101M
CHTR, Charter Communications	2.45%	New	1,111,341	$439.82	$489M	+1,111,341	+$489M
GOOG, Alphabet	2.35%, was 2.57%	Reduce −6.4%	3,557,140	$131.85	$469M	−245,000	+$9.1M
MSFT, Microsoft	2.14%, was 1.64%	Add +56.7%	1,349,178	$315.75	$426M	+488,000	+$133M
ARMK, Aramark	2.11%	Add +11.5%	12,136,200	$34.70	$421M	+1,249,316	−$48M
AZNN	2.06%	Hold	6,059,553	$67.72	$410M	—	—
SPGI, S&P Global	1.83%, was 2.43%	Reduce −8.0%	999,395	$365.41	$365M	−86,900	−$70M
WAB, Wabtec	1.73%	Add +0.4%	3,256,047	$106.27	$346M	+14,117	−$9.5M
ADI, Analog Devices	1.70%, was 2.26%	Reduce −6.4%	1,942,000	$175.09	$340M	−133,000	−$64M
CBRE, CBRE Group	1.67%	New	4,520,388	$73.86	$334M	+4,520,388	+$334M
NYT, New York Times	1.64%	Hold	7,964,791	$41.20	$328M	—	—
CNC, Centene	1.53%, was 1.78%	Reduce −6.0%	4,445,075	$68.88	$306M	−284,000	−$13M
INTU, Intuit	1.42%, was 1.77%	Reduce −19.6%	556,100	$510.94	$284M	−135,200	−$33M
YMM, Full Truck Alliance	1.35%, was 1.59%	Reduce −16.7%	38,190,495	$7.04	$269M	−7,667,743	−$16M
SHW, Sherwin-Williams	1.34%, was 2.04%	Reduce −23.9%	1,046,792	$255.05	$267M	−328,600	−$98M
NOW, ServiceNow	1.34%, was 1.56%	Reduce −3.9%	477,550	$558.96	$267M	−19,500	−$12M
BSX, Boston Scientific	1.33%, was 1.52%	Reduce −0.1%	5,039,257	$52.80	$266M	−6,000	−$6.8M
MA, Mastercard	1.20%, was 1.72%	Reduce −22.7%	606,471	$395.91	$240M	−178,300	−$69M
BX, Blackstone	1.20%, was 1.59%	Reduce −27.2%	2,227,051	$107.14	$239M	−831,200	−$46M
HWM, Howmet Aerospace	1.10%, was 1.62%	Reduce −18.9%	4,747,627	$46.25	$220M	−1,110,000	−$71M
AON, Aon	1.08%, was 1.60%	Reduce −19.6%	665,661	$324.22	$216M	−162,125	−$70M
CSGP, CoStar Group	1.07%	Add +1.3%	2,786,856	$76.89	$214M	+35,800	−$31M
HUM, Humana	0.89%, was 0.65%	Add +41.0%	364,461	$486.52	$177M	+106,000	+$62M
V, Visa	0.88%, was 1.38%	Reduce −26.7%	761,410	$230.01	$175M	−277,900	−$72M
Sarepta Therapeutics	0.84%, was 0.77%	Add +14.1%	1,375,200	$121.22	$167M	+170,000	+$29M
ELV, Elevance Health	0.83%, was 1.11%	Reduce −14.4%	381,330	$435.42	$166M	−64,000	−$32M
LNTH, Lantheus	0.56%	Add +17.5%	1,598,500	$69.48	$111M	+238,000	−$3.1M
BEAM, Beam Therapeutics	0.54%	Add +30.2%	4,481,839	$24.05	$108M	+1,040,317	−$2.1M
CI, Cigna	0.52%, was 0.34%	Add +67.9%	366,000	$286.07	$105M	+148,000	+$44M
XYZ, Block	0.52%, was 1.24%	Reduce −30.1%	2,336,350	$44.26	$103M	−1,007,700	−$119M
NTRA, Natera	0.51%, was 0.36%	Add +72.0%	2,277,883	$44.25	$101M	+953,700	+$36M
RVMD, Revolution Medicines	0.46%, was 0.42%	Add +19.5%	3,325,480	$27.68	$92M	+542,000	+$18M
PTGX, Protagonist Therapeutics	0.46%	Add +20.7%	5,446,430	$16.68	$91M	+935,000	−$34M
PACB	0.43%	Add +22.6%	10,224,120	$8.35	$85M	+1,886,000	−$26M
INSP, Inspire Medical Systems	0.42%	Add +31.9%	426,096	$198.44	$85M	+103,000	−$20M
BABA, Alibaba	0.37%, was 0.87%	Reduce −53.9%	862,233	$86.74	$75M	−1,007,767	−$81M
BEKE, KE Holdings	0.37%	Hold	4,758,500	$15.52	$74M	—	—
VRTX, Vertex Pharmaceuticals	0.35%	New	202,000	$347.74	$70M	+202,000	+$70M
PCG, PG&E	0.34%, was 0.48%	Reduce −15.7%	4,221,642	$16.13	$68M	−783,500	−$18M
AGIO, Agios Pharmaceuticals	0.34%	Add +2.3%	2,750,829	$24.75	$68M	+62,000	−$8.1M
THC, Tenet Healthcare	0.34%	Add +37.0%	1,030,000	$65.89	$68M	+278,000	+$6.7M
SIMO, Silicon Motion Technology	0.27%	New	1,045,000	$51.25	$54M	+1,045,000	+$54M
EVH, Evolent Health	0.26%	Hold	1,900,909	$27.23	$52M	—	—
DXCM, DexCom	0.25%	New	544,000	$93.30	$51M	+544,000	+$51M
NBIX, Neurocrine Biosciences	0.25%	New	448,000	$112.50	$50M	+448,000	+$50M
ROIV, Roivant Sciences	0.23%, was 0.13%	Add +63.6%	3,853,400	$11.68	$45M	+1,498,400	+$21M
Mirati Therapeutics	0.22%	New	1,001,000	$43.56	$44M	+1,001,000	+$44M
HCA, HCA Healthcare	0.22%, was 0.45%	Reduce −33.5%	174,400	$245.98	$43M	−88,000	−$37M
Denbury	0.21%	New	425,000	$98.01	$42M	+425,000	+$42M
Savara	0.21%	Hold	10,908,086	$3.78	$41M	—	—
IONS, Ionis Pharmaceuticals	0.17%	Add +14440.0%	727,000	$45.36	$33M	+722,000	+$33M
CRL, Charles River Labs International	0.14%	New	146,000	$195.98	$29M	+146,000	+$29M
OPCH, Option Care Health	0.14%, was 0.38%	Reduce −58.3%	862,000	$32.35	$28M	−1,205,134	−$39M
ENTA, Enanta Pharmaceuticals	0.10%	Hold	1,875,000	$11.17	$21M	—	—
United States Steel	0.10%	New	635,000	$32.48	$21M	+635,000	+$21M
Masimo	0.10%, was 0.34%	Reduce −38.1%	227,649	$87.68	$20M	−140,000	−$41M
BHVN, Biohaven	0.10%	Hold	750,000	$26.01	$20M	—	—
IMVT, Immunovant	0.10%	New	504,000	$38.39	$19M	+504,000	+$19M
Sdcl Edge Acquisition	0.09%	Hold	1,732,500	$10.60	$18M	—	—
National Instruments	0.08%	New	265,000	$59.62	$16M	+265,000	+$16M
Ares Acquisition	0.08%	Hold	1,425,000	$10.76	$15M	—	—
Zymeworks	0.06%	Hold	2,000,000	$6.34	$13M	—	—
Earthstone Energy	0.06%	New	618,831	$20.24	$13M	+618,831	+$13M
TAL, Tal Education Group	0.06%	New	1,365,000	$9.11	$12M	+1,365,000	+$12M
SLNO, Soleno Therapeutics	0.06%	New	388,000	$29.51	$11M	+388,000	+$11M
Chindata Group	0.05%	New	1,300,000	$8.30	$11M	+1,300,000	+$11M
CRNX	0.05%	New	361,904	$29.74	$11M	+361,904	+$11M
Screaming Eagle Acquisitn	0.05%	Hold	1,000,000	$10.46	$10M	—	—
VYGR, Voyager Therapeutics	0.05%	Hold	1,292,000	$7.75	$10M	—	—
AXSM, Axsome Therapeutics	0.04%, was 0.11%	Reduce −53.9%	125,653	$69.89	$8.8M	−147,147	−$11M
RIO, Rio Tinto	0.04%	Hold	137,500	$63.64	$8.8M	—	—
Holding	0.04%	Add +56.1%	1,560,500	$5.56	$8.7M	+560,500	+$1.3M
APLS, Apellis Pharmaceuticals	0.04%, was 0.02%	Add +384.5%	194,053	$38.04	$7.4M	+154,000	+$3.7M
Slam	0.03%	Hold	570,396	$10.78	$6.1M	—	—
VNET, Vnet Group	0.03%	Hold	1,775,000	$3.13	$5.6M	—	—
Gores Holdings IX	0.03%	Hold	500,000	$10.39	$5.2M	—	—
Gossamer Bio	0.03%	New	6,130,272	$0.8328	$5.1M	+6,130,272	+$5.1M
NDAQ, Nasdaq	0.02%	New	102,500	$48.59	$5M	+102,500	+$5M
Holding	0.02%	Hold	400,000	$10.38	$4.2M	—	—
Swiftmerge Acquisition	0.02%	Hold	300,000	$10.63	$3.2M	—	—
Berenson Acquisition	0.01%	Hold	285,715	$10.37	$3M	—	—
Verve Therapeutics	0.01%	New	211,293	$13.26	$2.8M	+211,293	+$2.8M
Cara Therapeutics	0.01%	Hold	1,666,591	$1.68	$2.8M	—	—
TVTX, Travere Therapeutics	0.01%	New	271,517	$8.94	$2.4M	+271,517	+$2.4M
Arya Sciences Acqu Corporation IV	0.01%	Hold	200,000	$10.85	$2.2M	—	—
Marblegate Acquisition	0.01%	Hold	150,000	$10.44	$1.6M	—	—
Forte Biosciences	0.01%	New	1,810,455	$0.6620	$1.2M	+1,810,455	+$1.2M
OKLO, Altc Acquisition	0.01%	Hold	98,300	$10.35	$1M	—	—
Summit Midstream Partners	0.00%	Hold	58,214	$13.85	$806K	—	—
EDU	0.00%	Hold	13,000	$58.55	$761K	—	—
CYTK, Cytokinetics	0.00%	Hold	21,772	$29.46	$641K	—	—
Lufax	0.00%, was 0.16%	Reduce −97.0%	600,000	$1.06	$636K	−19,349,819	−$28M
MDGL, Madrigal Pharmaceuticals	0.00%	Hold	3,319	$146.04	$485K	—	—
BNTX, Biontech	0.00%	Hold	3,844	$108.64	$418K	—	—
Karuna Therapeutics	0.00%	Hold	2,200	$169.09	$372K	—	—
ALNY, Alnylam Pharmaceuticals	0.00%	Hold	2,000	$177.10	$354K	—	—
EHC, Encompass Health	0.00%, was 0.04%	Reduce −97.0%	3,000	$67.16	$201K	−97,000	−$6.6M
Blueprint Medicines	0.00%, was 0.01%	Reduce −82.2%	4,000	$50.22	$201K	−18,420	−$1.2M
R1 RCM	0.00%, was 0.06%	Reduce −97.8%	12,000	$15.07	$181K	−540,000	−$10M
COGT, Cogent Biosciences	0.00%, was 0.07%	Reduce −98.3%	17,000	$9.75	$166K	−966,452	−$11M

Showing top 50 of 107 by value

Exits / last held

Gone since 2023 Q2, shown at their last reported size.

Stock	% of portfolio	Recent activity	Reported price*	Value	Share change	$ change
EFX, Equifax	1.39%	Exit	$235.30	$249M	−1,058,697	−$249M
BIIB, Biogen	0.96%	Exit	$284.85	$172M	−604,098	−$172M
Iveric Bio	0.54%	Exit	$39.34	$96M	−2,442,299	−$96M
ARGX, Argenx	0.35%	Exit	$389.73	$63M	−161,000	−$63M
Chinook Therapeutics	0.33%	Exit	$38.42	$59M	−1,523,000	−$59M
Exact Sciences	0.32%	Exit	$93.90	$57M	−602,000	−$57M
Aerojet Rocketdyne	0.29%	Exit	$54.87	$53M	−959,378	−$53M
Reata Pharmaceuticals	0.26%	Exit	$101.96	$46M	−451,700	−$46M
UTHR, United Therapeutics	0.24%	Exit	$220.75	$43M	−193,267	−$43M
Ambrx Biopharma	0.21%	Exit	$16.46	$37M	−2,269,000	−$37M
AIG, American Eqty Investment Life HLD	0.11%	Exit	$52.11	$20M	−383,000	−$20M
Life Storage	0.07%	Exit	$132.96	$12M	−89,794	−$12M
BRKR, Bruker	0.06%	Exit	$73.92	$11M	−150,476	−$11M
Holding	0.05%	Exit	$10.56	$8.2M	−775,200	−$8.2M
Holding	0.04%	Exit	$10.35	$7.7M	−745,000	−$7.7M
Corsair Partnering	0.04%	Exit	$10.37	$7.3M	−700,000	−$7.3M
Blue Whale Acquisition	0.03%	Exit	$10.15	$5.8M	−575,000	−$5.8M
INTC, Intellia Therapeutics	0.03%	Exit	$40.78	$4.7M	−116,000	−$4.7M
Finserv Acquisition Corporation II	0.02%	Exit	$10.23	$4.1M	−400,000	−$4.1M
Cartica Acquisition	0.02%	Exit	$10.67	$3.7M	−350,000	−$3.7M
Uta Acquisition	0.02%	Exit	$10.57	$3.6M	−344,100	−$3.6M
ALVO, Alvotech	0.02%	Exit	$7.74	$3.4M	−437,110	−$3.4M
Atento	0.01%	Exit	$0.9998	$2.2M	−2,230,357	−$2.2M
PRVA, Privia Health Group	0.01%	Exit	$26.11	$1.9M	−74,000	−$1.9M
ICE, Intercontinental Exchange	0.01%	Exit	$113.09	$1.4M	−12,786	−$1.4M
Avrobio	—	Exit	$0.9503	$855K	−899,700	−$855K
Better Therapeutics	—	Exit	$1.08	$357K	−330,619	−$357K
Clever Leaves	—	Exit	$0.2025	$330K	−1,629,363	−$330K
ARWR, Arrowhead Pharmaceuticals	—	Exit	$35.69	$207K	−5,800	−$207K

Filings history

20 periods, with AUM normalized

Newest 13Fs

Period	Holds	AUM	QoQ	Form	Filed	Filing ID
2026 Q2	89	$21.7B	+23.6%	13F-HR	8/14/2026	000090883426000432
2026 Q1	1	$1.5B	—	new holds	8/14/2026	000090883426000434
2026 Q1	172	$17.5B	−17.2%	13F-HR	5/15/2026	000090883426000240
2025 Q4	1	$1B	—	new holds	8/14/2026	000090883426000433
2025 Q4	2	$884M	—	new holds	5/15/2026	000090883426000241
2025 Q4	151	$21.2B	−13.2%	13F-HR	2/17/2026	000090883426000087
2025 Q3	144	$24.4B	—	RESTATEMENT	2/17/2026	000090883426000086
2025 Q3	144	$24.4B	+5.4%	13F-HR	11/14/2025	000090883425000353
2025 Q2	1	$140M	—	new holds	2/17/2026	000090883426000085
2025 Q2	3	$483M	—	new holds	11/14/2025	000090883425000352
2025 Q2	141	$23.2B	+29.2%	13F-HR	8/14/2025	000090883425000248
2025 Q1	1	$274M	—	new holds	2/17/2026	000090883426000084
2025 Q1	3	$416M	—	new holds	11/14/2025	000090883425000351
2025 Q1	7	$2.2B	—	new holds	8/14/2025	000090883425000247
2025 Q1	135	$17.9B	−9.0%	13F-HR	5/15/2025	000090883425000177
2024 Q4	1	$85M	—	new holds	2/17/2026	000090883426000083
2024 Q4	2	$349M	—	new holds	11/14/2025	000090883425000350
2024 Q4	6	$2.3B	—	new holds	8/14/2025	000090883425000246
2024 Q4	4	$333M	—	new holds	5/15/2025	000090883425000180
2024 Q4	138	$19.7B	−3.5%	13F-HR	2/14/2025	000090883425000081
2024 Q3	1	$145M	—	new holds	11/14/2025	000090883425000349
2024 Q3	6	$1.5B	—	new holds	8/14/2025	000090883425000243
2024 Q3	3	$216M	—	new holds	5/15/2025	000090883425000179
2024 Q3	2	$544M	—	new holds	2/14/2025	000090883425000080
2024 Q3	153	$20.4B	−3.6%	13F-HR	11/14/2024	000090883424000307
2024 Q2	1	$120M	—	new holds	11/14/2025	000090883425000348
2024 Q2	5	$1.2B	—	new holds	8/14/2025	000090883425000245
2024 Q2	1	$199M	—	new holds	5/15/2025	000090883425000178
2024 Q2	2	$452M	—	new holds	2/14/2025	000090883425000079
2024 Q2	1	$149M	—	new holds	11/14/2024	000090883424000324
2024 Q2	157	$21.2B	−4.2%	13F-HR	8/14/2024	000090883424000200
2024 Q1	1	$93M	—	new holds	11/14/2025	000090883425000347
2024 Q1	4	$1.2B	—	new holds	8/14/2025	000090883425000244
2024 Q1	2	$159M	—	new holds	2/14/2025	000090883425000078
2024 Q1	1	$45M	—	new holds	8/14/2024	000090883424000202
2024 Q1	167	$22.1B	—	RESTATEMENT	5/24/2024	000090883424000159
2024 Q1	167	$22.1B	+9.8%	13F-HR	5/15/2024	000090883424000135
2023 Q4	1	$65M	—	new holds	11/14/2025	000090883425000346
2023 Q4	2	$548M	—	new holds	8/14/2025	000090883425000250
2023 Q4	5	$1.1B	—	new holds	5/15/2024	000090883424000141
2023 Q4	150	$20.1B	+1.0%	13F-HR	2/14/2024	000090883424000070
2023 Q3	1	$40M	—	new holds	11/14/2025	000090883425000345
2023 Q3	1	$40M	—	new holds	5/15/2024	000090883424000138
2023 Q3	2	$1.4B	—	new holds	2/14/2024	000090883424000077
2023 Q3	1	$1.9B	—	new holds	2/12/2024	000090883424000049
2023 Q3	159	$20B	+11.5%	13F-HR	11/14/2023	000090883423000150
2023 Q2	2	$669M	—	new holds	2/14/2024	000090883424000076
2023 Q2	5	$1.4B	—	new holds	11/14/2023	000090883423000157
2023 Q2	1	$1.2B	—	new holds	10/26/2023	000090883423000134
2023 Q2	165	$17.9B	+1.3%	13F-HR	8/14/2023	000090883423000109
2023 Q1	2	$234M	—	new holds	2/14/2024	000090883424000075
2023 Q1	3	$389M	—	new holds	11/14/2023	000090883423000156
2023 Q1	1	$15M	—	new holds	8/14/2023	000090883423000110
2023 Q1	187	$17.7B	+15.8%	13F-HR	5/15/2023	000117570723000127
2022 Q4	1	$171M	—	new holds	2/14/2024	000090883424000074
2022 Q4	3	$485M	—	new holds	11/14/2023	000090883423000155
2022 Q4	7	$1B	—	new holds	5/15/2023	000117570723000136
2022 Q4	232	$15.3B	−9.3%	13F-HR	2/14/2023	000117570723000051
2022 Q3	1	$125M	—	new holds	2/14/2024	000090883424000073
2022 Q3	3	$415M	—	new holds	11/14/2023	000090883423000154
2022 Q3	5	$411M	—	new holds	5/15/2023	000117570723000135
2022 Q3	4	$434M	—	new holds	2/14/2023	000090966123000005
2022 Q3	298	$16.8B	+3.5%	13F-HR	11/14/2022	000156761922019851
2022 Q2	1	$115M	—	new holds	2/14/2024	000090883424000081
2022 Q2	3	$411M	—	new holds	11/14/2023	000090883423000153
2022 Q2	2	$337M	—	new holds	5/15/2023	000117570723000134
2022 Q2	3	$136M	—	new holds	2/14/2023	000090966123000003
2022 Q2	9	$1.2B	—	new holds	11/14/2022	000156761922019862
2022 Q2	297	$16.3B	−13.7%	13F-HR	8/15/2022	000156761922015953
2022 Q1	1	$268M	—	new holds	11/14/2023	000090883423000152
2022 Q1	1	$314M	—	new holds	5/15/2023	000117570723000133
2022 Q1	1	$27M	—	new holds	2/14/2023	000090966123000002
2022 Q1	3	$186M	—	new holds	11/14/2022	000156761922019864
2022 Q1	8	$1.1B	—	new holds	8/15/2022	000156761922015972
2022 Q1	307	$18.8B	+0.4%	13F-HR	5/16/2022	000156761922010736
2021 Q4	1	$227M	—	new holds	5/15/2023	000117570723000132
2021 Q4	1	$7M	—	new holds	11/14/2022	000156761922019852
2021 Q4	1	$115M	—	new holds	8/15/2022	000156761922015968
2021 Q4	2	$98M	—	new holds	5/19/2022	000156761922011257
2021 Q4	6	$833M	—	new holds	5/16/2022	000156761922010757
2021 Q4	289	$18.7B	−5.1%	13F-HR	2/14/2022	000156761922003965
2021 Q3	1	$182M	—	new holds	5/15/2023	000117570723000131
2021 Q3	1	$105M	—	new holds	8/15/2022	000156761922015964
2021 Q3	1	$57M	—	new holds	5/19/2022	000156761922011256
2021 Q3	3	$998M	—	new holds	5/16/2022	000156761922010753
2021 Q3	2	$344M	—	new holds	2/14/2022	000156761922003981
2021 Q3	293	$19.7B	—	13F-HR	11/15/2021	000095012321015168

About

Farallon Capital Management, L.l.c.

87 processed 13Fs on this site, 2021 Q3 to 2026 Q2

SEC filing name: FARALLON CAPITAL MANAGEMENT, L.L.C.
Location: San Francisco, CA
All SEC filings: View on sec.gov